Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Resources Connection Reports Financial Results for Second Quarter Fiscal 2025
Resources Connection Reports Financial Results for Second Quarter Fiscal 2025


Resources Connection, Inc. (Nasdaq: RGP) (the “Company”), a professional services firm, today announced its financial results for its second quarter of fiscal 2025 ended November 23, 2024.

ISG Advisors Recognized as 2024 HRO Today Superstars
ISG Advisors Recognized as 2024 HRO Today Superstars


HRO Today has named two advisors from Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm, as 2024 HRO Today Superstars for helping enterprises

Interactive Brokers Group Reports Brokerage Metrics and Other Financial Information for December 2024, includes Reg.-NMS Execution Statistics
Interactive Brokers Group Reports Brokerage Metrics and Other Financial Information for December 2024, includes Reg.-NMS Execution Statistics


Interactive Brokers Group, Inc. (Nasdaq: IBKR) an automated global electronic broker, today reported its Electronic Brokerage monthly performance metrics for December.



Brokerage highlights for

Marsh McLennan to Host Fourth Quarter Earnings Investor Call on January 30
Marsh McLennan to Host Fourth Quarter Earnings Investor Call on January 30


Marsh McLennan (NYSE: MMC), a global leader in risk, strategy and people, will announce fourth quarter financial results via news release on Thursday, January 30, 2025, before the market opens. The

Interactive Brokers Group to Host Fourth Quarter Earnings Conference Call
Interactive Brokers Group to Host Fourth Quarter Earnings Conference Call


Interactive Brokers Group, Inc. (Nasdaq: IBKR) plans to announce its fourth quarter financial results on Tuesday, January 21, 2025, in a release that will be issued at approximately 4:00 pm (ET)

QuidelOrtho to Present at the 43rd Annual J.P. Morgan Healthcare Conference: https://s24.q4cdn.com/594651504/files/design/QO_Logo_FINAL.png
QuidelOrtho to Present at the 43rd Annual J.P. Morgan Healthcare Conference


QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine

Sangamo Therapeutics to Regain Full Rights to Hemophilia A Gene Therapy Program Following Pfizer’s Decision to Cease Development of Giroctocogene Fitelparvovec
Sangamo Therapeutics to Regain Full Rights to Hemophilia A Gene Therapy Program Following Pfizer’s Decision to Cease Development of Giroctocogene Fitelparvovec


Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced it will regain development and commercialization rights to giroctocogene fitelparvovec, an investigational

America’s Renters Are Moving Less Than Ever, With a Third Staying in the Same Home for at Least 5 Years
America’s Renters Are Moving Less Than Ever, With a Third Staying in the Same Home for at Least 5 Years


(NASDAQ: RDFN) — A third (33.6%) of U.S. renters have lived in the same home for at least five years, up from 28.4% a decade ago. That’s according to a new report from Redfin (redfin.com), the

Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device
Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has received U.S. Food and Drug

Redfin Reports Housing Supply Just Hit a Four-Year High, Partly Because So Many Homes Are Sitting on the Market Unsold
Redfin Reports Housing Supply Just Hit a Four-Year High, Partly Because So Many Homes Are Sitting on the Market Unsold


(NASDAQ: RDFN) — Active listings—the total number of homes for sale—climbed to the highest level since 2020 in November on a seasonally adjusted basis, rising 0.5% month over month and 12.1% year

T-Mobile to Host Q4 and Full Year 2024 Earnings Call on January 29, 2025
T-Mobile to Host Q4 and Full Year 2024 Earnings Call on January 29, 2025


T-Mobile US, Inc. (NASDAQ: TMUS) looks forward to discussing fourth quarter and full year 2024 financial and operational results on Wednesday, January 29, 2025, at 8:00 a.m. Eastern Time (ET). The

T-Mobile to Host Q4 and Full Year 2024 Earnings Call on January 29, 2025
T-Mobile to Host Q4 and Full Year 2024 Earnings Call on January 29, 2025


T-Mobile US, Inc. (NASDAQ: TMUS) looks forward to discussing fourth quarter and full year 2024 financial and operational results on Wednesday, January 29, 2025, at 8:00 a.m. Eastern Time (ET). The

T-Mobile to Host Q4 and Full Year 2024 Earnings Call on January 29, 2025
T-Mobile to Host Q4 and Full Year 2024 Earnings Call on January 29, 2025


T-Mobile US, Inc. (NASDAQ: TMUS) looks forward to discussing fourth quarter and full year 2024 financial and operational results on Wednesday, January 29, 2025, at 8:00 a.m. Eastern Time (ET). The

Redfin Reports Housing Supply Ends 2024 On the Rise, Up 12% Year Over Year
Redfin Reports Housing Supply Ends 2024 On the Rise, Up 12% Year Over Year


(NASDAQ: RDFN) — Active listings climbed 12% year over year during the four weeks ending December 22, though that was the smallest increase since March, according to a new report from Redfin (redfi

Discover Financial Services Announces Fourth Quarter 2024 Earnings Release on January 22, 2025, and Conference Call on January 23, 2025
Discover Financial Services Announces Fourth Quarter 2024 Earnings Release on January 22, 2025, and Conference Call on January 23, 2025


Discover Financial Services (NYSE: DFS) plans to report its Fourth quarter 2024 results after the market closes on Wednesday, January 22, 2025. The earnings release will be available through

Equity Bancshares, Inc. Will Announce Fourth Quarter 2024 Results on January 22, 2025
Equity Bancshares, Inc. Will Announce Fourth Quarter 2024 Results on January 22, 2025


Equity Bancshares, Inc. (NYSE:EQBK), (“Equity”), the Wichita-based holding company of Equity Bank, will release its fourth quarter results on Wednesday, January 22, 2025, with a press release

Martin Midstream Partners L.P. Announces Termination of Merger Agreement and Cancellation of Special Meeting
Martin Midstream Partners L.P. Announces Termination of Merger Agreement and Cancellation of Special Meeting


Martin Midstream Partners L.P. (“MMLP”) (Nasdaq: MMLP) today announced the termination of the previously announced Agreement and Plan of Merger (the “Merger Agreement”), dated October 3, 2024, with

Redfin Reports U.S. Home Prices Rose 0.5% in November
Redfin Reports U.S. Home Prices Rose 0.5% in November


(NASDAQ: RDFN) — U.S. home prices grew 0.5% from a month earlier in November on a seasonally adjusted basis, the third consecutive month with a 0.5% increase. That’s according to a new report from

Savara Announces New Employment Inducement Grant
Savara Announces New Employment Inducement Grant


Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to five new employees.



On December 20

Bankwell Financial Group Director, Lawrence B. Seidman, Approved to Increase Position in Company
Bankwell Financial Group Director, Lawrence B. Seidman, Approved to Increase Position in Company


Bankwell Financial Group, Inc. (NASDAQ: BWFG), the parent company of Bankwell Bank, has announced board approval of a measure that will allow individual shareholder and director, Lawrence B

Puma Biotechnology’s NERLYNX® Included in NCCN Clinical Practice Guidelines for the Treatment of Cervical Cancer with a HER2 Mutation
Puma Biotechnology’s NERLYNX® Included in NCCN Clinical Practice Guidelines for the Treatment of Cervical Cancer with a HER2 Mutation


Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for

Redfin Reports Home Sales Surge by Double Digits in Pricey West Coast Markets
Redfin Reports Home Sales Surge by Double Digits in Pricey West Coast Markets


(NASDAQ: RDFN) — In Portland, OR, home sales jumped 27.6% year over year in November—the biggest increase among the 50 most populous U.S. metropolitan areas, according to a new report from Redfin (

Mettler-Toledo International Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Mettler-Toledo International Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference


Mettler-Toledo International Inc. (NYSE: MTD) today announced it will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 14, 2025 at 3:45 p.m

U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer
U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer


Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and mFOLFOX6

U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer
U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer


Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and mFOLFOX6